Details of the Drug

General Information of Drug (ID: DMOTBX5)

• Drug Name: Deferitrin
• Synonyms: GT-56-252; Desferrithiocin analogs (iron overload), SunPharm/Schein; Iron chelators (iron overload), GelTex/Schein

Indication

Disease Entry	ICD 11	Status	REF
Iron overload disease	5C64.10	Phase 1/2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C11H11NO4S
  Canonical SMILES: CC1(CSC(=N1)C2=C(C=C(C=C2)O)O)C(=O)O
  InChI: InChI=1S/C11H11NO4S/c1-11(10(15)16)5-17-9(12-11)7-3-2-6(13)4-8(7)14/h2-4,13-14H,5H2,1H3,(H,15,16)/t11-/m1/s1
  InChIKey: OEUUFNIKLCFNLN-LLVKDONJSA-N
• Cross-matching ID:
  PubChem CID: 135413558
  CAS Number: 239101-33-8
  UNII: T69Y9LDN44
  DrugBank ID: DB16132
  TTD ID: D09PSZ
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] ClinicalTrials.gov (NCT00069862) Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia. U.S. National Institutes of Health.